Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast CancerLuigi Tarantini, Pompilio Faggiano, Daniella Bovelli et al.|Journal of Cardiac Failure|2011Cited by 116
Administration of Angiotensin-Converting Enzyme Inhibitors and <i>β</i>-Blockers During Adjuvant Trastuzumab Chemotherapy for Nonmetastatic Breast Cancer: Marker of Risk or Cardioprotection in the Real World?Stefano Oliva, Giovanni Cioffi, Silvia Frattini et al.|The Oncologist|2012Cited by 49
Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancerGiulia Russo, Luigi Tarantini, Giovanni Cioffi et al.|Journal of Cardiovascular Medicine|2014Cited by 27